Bristol-Myers Squibb (NYSE:BMY – Get Free Report) is scheduled to be issuing its quarterly earnings data before the market ...

Bristol Myers Squibb (BMY) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to ...

Shares of Bristol Myers Squibb Co. BMY advanced 1.23% to $52.76 Tuesday, on what proved to be an all-around poor trading ...

On Tuesday, Bristol-Myers Squibb Co (BMY) stock saw a modest uptick, ending the day at $52.76 which represents a slight increase of $0.64 or 1.23% from the prior close of $52.12. The stock opened at ...

Bristol-Myers Squibb (BMY – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst David Risinger from Leerink Partners maintained a Hold rating on ...

We recently compiled a list of the Jim Cramer’s Exclusive List of 9 YEV Stocks. In this article, we are going to take a look ...

Key scientific achievements drive the expansion of the pipeline of molecular glue degraders in fields beyond oncology Evotec ...

SS&H Financial Advisors Inc. lifted its holdings in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 3.7% in the third ...

Evotec stock is up following progress in its partnership with Bristol Myers Squibb, including a $50 million payment.

On Friday, Bristol-Myers Squibb Co (BMY) stock saw a decline, ending the day at $52.2 which represents a decrease of $-0.20 or -0.38% from the prior close of $52.4. The stock opened at $52.58 and ...

The Bristol Myers Squibb Foundation, an independent charitable organization, has awarded Baylor College of Medicine Global Health $2.25 million for ...

Evotec announced in May of 2022 that the Company has further extended and expanded its partnership with Bristol Myers Squibb for another 8 years as the initial collaboration proved to be highly ...